CDT Equity (CDT) Interest Coverage Ratio (2022 - 2026)
CDT Equity's (CDT) quarterly Interest Coverage Ratio came in at 9.14 in Q1 2026, down 178.04% YoY from 11.71 in Q1 2025, and down 153.89% on a QoQ basis from 16.96 in Q4 2025.
CDT Equity (CDT) Interest Coverage Ratio (2022 - 2026) Analysis & Trends
CDT Equity (CDT) has 5 years of Interest Coverage Ratio data on file, last reported at 9.14 in Q1 2026.
- Quarterly Interest Coverage Ratio fell 178.04% year-over-year to 9.14 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 85.67 (down 5228.45% YoY) and the FY2025 annual result came in at 4.09, down 57.32% from the prior year.
- Interest Coverage Ratio eased to 9.14 in Q1 2026, from 16.96 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 16.96 in Q4 2025 to a low of 37.21 in Q3 2025.
- A 5-year average of 4.08 and a median of 2.18 in 2022 frame the typical range for Interest Coverage Ratio.
- The widest YoY moves for Interest Coverage Ratio: up 2937.05% in 2025, down 4349.78% in 2025.
- Tracing CDT's Interest Coverage Ratio over 5 years: stood at 1.23 in 2022, then soared by 232.73% to 1.63 in 2023, then plunged by 136.67% to 0.6 in 2024, then jumped by 2937.05% to 16.96 in 2025, then sank by 153.89% to 9.14 in 2026.
- The last three Interest Coverage Ratio figures came in at 9.14 (Q1 2026), 16.96 (Q4 2025), and 37.21 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | CDT Equity | 1.55 Mn | 1.55 Mn | - | -1.95 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.95 |
| Mar 31, 2026 | -9.14 |
| Dec 31, 2025 | 16.96 |
| Sep 30, 2025 | -37.21 |
| Jun 30, 2025 | -4.54 |
| Mar 31, 2025 | -3.29 |
| Dec 31, 2024 | -0.60 |
| Sep 30, 2024 | -8.21 |
| Jun 30, 2024 | -1.34 |
| Mar 31, 2024 | -0.07 |
| Dec 31, 2023 | 1.63 |
| Sep 30, 2023 | -1.73 |
| Jun 30, 2023 | -0.80 |
| Mar 31, 2023 | -5.17 |
| Dec 31, 2022 | -1.23 |
| Sep 30, 2022 | -7.91 |
| Mar 31, 2022 | -2.64 |